New study tests if rehumanizing thoughts can reduce suicidal ideation
NCT ID NCT06713473
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores whether reducing feelings of being 'less than human' can lower suicidal thoughts and increase oxytocin levels. Fifty adults aged 18-40 with moderate self-dehumanization and current suicidal thoughts will be randomly assigned to a rehumanization exercise or a control group. Researchers will measure changes in suicidal ideation and blood oxytocin levels before and after the intervention.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward a new psychological approach to reduce suicide risk by addressing feelings of dehumanization.
- What could go wrong
- This is a small, early-stage study with only 50 participants, so results may not apply broadly. It tests a brief intervention, not a treatment, and may show no significant effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Between the ages of 18 and 40 * Biological females will be screened to ensure that they have a regular menstrual cycle with a length of 26-30 days and will be scheduled according to their cycle (see Research Strategy for details). * At least a moderate level of self-dehumanization (i.e., a sum score of 12 or greater out of a possible score of 28) and current suicidal ideation Exclusion Criteria: * Participation in the Self-Dehumanized Study by this study team * A phobia of needles (i.e., trypanophobia) * Any medical conditions precluding them from engaging in a 10-hour fast (consumption of water is allowed and encouraged) * Life-threatening suicide risk which would result in taking appropriate steps to ensure safety of the individual (e.g., hospitalization) A psychosis-related diagnosis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Control intervention are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Florida State University
Tallahassee, Florida, 32304, United States